AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Mentre, F Dubruc, C Thenot, JP
Citation: F. Mentre et al., Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children, J PHARMA PH, 28(3), 2001, pp. 299-319

Authors: Lechat, P Lardoux, H Mallet, A Sanchez, P Derumeaux, G Lecompte, T Maillard, L Mas, JL Mentre, F Pousset, F Lacomblez, I Pisica, G Solbes-Latourette, S Raynaud, P Chaumet-Riffaud, P
Citation: P. Lechat et al., Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation - A randomized trial (fluindione, fibrillation auriculaire, aspirin et contraste spontane; FFAACS), CEREB DIS, 12(3), 2001, pp. 245-252

Authors: Aarons, L Karlsson, MO Mentre, F Rombout, F Steimer, JL van Peer, A
Citation: L. Aarons et al., Role of modelling and simulation in Phase I drug development, EUR J PH SC, 13(2), 2001, pp. 115-122

Authors: Duffull, SB Mentre, F Aarons, L
Citation: Sb. Duffull et al., Optimal design of a population pharmacodynamic experiment for ivabradine, PHARM RES, 18(1), 2001, pp. 83-89

Authors: Retout, S Duffull, S Mentre, F
Citation: S. Retout et al., Development and implementation of the population Fisher information matrixfor the evaluation of population pharmacokinetic designs, COMPUT M PR, 65(2), 2001, pp. 141-151

Authors: Bert, F Galdbart, JO Zarrouk, V Le Mee, J Durand, F Mentre, F Belghiti, J Lambert-Zechovsky, N Fantin, B
Citation: F. Bert et al., Association between nasal carriage of Staphylococcus aureus and infection in liver transplant recipients, CLIN INF D, 31(5), 2000, pp. 1295-1299

Authors: Comets, E Pousset, F Mentre, F Diquet, B Ankri, A Mallet, A Lechat, P
Citation: E. Comets et al., Prediction of fluindione maintenance dosage hampered by large intraindividual variability, THER DRUG M, 22(6), 2000, pp. 668-675

Authors: Comets, E Mentre, F Kawai, R Nimmerfall, F Marbach, P Vonderscher, J
Citation: E. Comets et al., Modeling the kinetics of release of octreotide from long-acting formulations injected intramuscularly in rabbits, J PHARM SCI, 89(9), 2000, pp. 1123-1133

Authors: Deschamps, C Dubruc, C Mentre, F Rosenzweig, P
Citation: C. Deschamps et al., Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model, CLIN PHARM, 68(6), 2000, pp. 647-657

Authors: Comets, E Mentre, F Nimmerfall, F Kawai, R Mueller, I Marbach, P Vonderscher, J
Citation: E. Comets et al., Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR, J CONTR REL, 59(2), 1999, pp. 197-205

Authors: Mentre, F Kovarik, J Gerbeau, C
Citation: F. Mentre et al., Constructing a prediction interval for time to reach a threshold concentration based on a population pharmacokinetic analysis: An application to basiliximab in renal transplantation, J PHAR BIOP, 27(2), 1999, pp. 213-230

Authors: Merle, Y Mentre, F
Citation: Y. Merle et F. Mentre, Optimal sampling times for Bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring, J PHAR BIOP, 27(1), 1999, pp. 85-101

Authors: Mentre, F Golmard, JL Launay, JM Aubin-Brunet, V Bouhassira, M Jouvent, R
Citation: F. Mentre et al., Relationships between low red blood cell count and clinical response to fluoxetine in depressed elderly patients, PSYCHIAT R, 81(3), 1998, pp. 403-405

Authors: Tod, M Mentre, F Merle, Y Mallet, A
Citation: M. Tod et al., Robust optimal design for the estimation of hyperparameters in population pharmacokinetics, J PHAR BIOP, 26(6), 1998, pp. 689-716
Risultati: 1-14 |